Publicaciones en colaboración con investigadores/as de Hospital Universitario de Basurto (182)

2024

  1. All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis

    Molecular Psychiatry

  2. Clinical and Epidemiological Characteristics of the 2022 Mpox Outbreak in Spain (CEME-22 Study)

    Open Forum Infectious Diseases, Vol. 11, Núm. 3

  3. Impacto del sexo en los tiempos de cateterismo y en el uso de pretratamiento antiagregante plaquetario en pacientes con síndrome coronario agudo sin elevación del segmento ST (SCASEST)

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 36, Núm. 2, pp. 123-130

  4. Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study

    Neurologia

  5. Is Alpha-Gal an Emerging Allergen in Drug Allergy?

    Current Treatment Options in Allergy

  6. Paired Primary and Recurrent Rhabdoid Meningiomas: Cytogenetic Alterations, BAP1 Gene Expression Profile and Patient Outcome

    Biology, Vol. 13, Núm. 5

  7. RE-START: Exploring the effectiveness of anti-calcitonin gene-related peptide resumption after discontinuation in migraine

    European Journal of Neurology, Vol. 31, Núm. 4

  8. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

  9. Timing of coronary angiography and use of antiplatelet pretreatment in patients with NSTEACS in Spain

    Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 234-242

2023

  1. Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

    Seminars in Arthritis and Rheumatism, Vol. 58

  2. Clinical and Treatment Outcome Differences Between the Most Common Nontuberculous Mycobacteria (NTM) in the Basque Country

    Archivos de Bronconeumologia, Vol. 59, Núm. 11, pp. 765-767

  3. Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  4. Development and Validation of a Prediction Model and Score for Transthyretin Cardiac Amyloidosis Diagnosis: T-Amylo

    JACC: Cardiovascular Imaging, Vol. 16, Núm. 12, pp. 1567-1580

  5. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study

    Neurology and Therapy, Vol. 12, Núm. 6, pp. 2177-2193

  6. Identification of a HIV-1 circulating BF1 recombinant form (CRF75_BF1) of Brazilian origin that also circulates in Southwestern Europe

    Frontiers in Microbiology, Vol. 14

  7. Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry

    Journal of Headache and Pain, Vol. 24, Núm. 1

  8. Long-term outcomes of extended DAPT in a real-life cohort of consecutive STEMI patients

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 548-554

  9. Psychosis and substance abuse increase the COVID-19 mortality risk

    Psychological Medicine, Vol. 53, Núm. 9, pp. 4236-4244

2022

  1. An NMR-Based Model to Investigate the Metabolic Phenoreversion of COVID-19 Patients throughout a Longitudinal Study

    Metabolites, Vol. 12, Núm. 12

  2. Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

    Seminars in Arthritis and Rheumatism, Vol. 52